DV Trading LLC Grows Holdings in SPDR S&P Biotech ETF $XBI

DV Trading LLC increased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 904.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,074 shares of the exchange traded fund’s stock after acquiring an additional 12,673 shares during the quarter. DV Trading LLC’s holdings in SPDR S&P Biotech ETF were worth $1,798,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently bought and sold shares of the business. Avoro Capital Advisors LLC purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter worth about $256,053,000. Bank of America Corp DE increased its stake in shares of SPDR S&P Biotech ETF by 13.3% during the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock valued at $1,854,388,000 after purchasing an additional 1,700,851 shares in the last quarter. Wells Fargo & Company MN lifted its holdings in shares of SPDR S&P Biotech ETF by 75.7% during the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after purchasing an additional 1,536,122 shares during the last quarter. OMERS ADMINISTRATION Corp lifted its holdings in shares of SPDR S&P Biotech ETF by 42,425.2% during the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock valued at $145,147,000 after purchasing an additional 1,187,907 shares during the last quarter. Finally, Morgan Stanley lifted its holdings in shares of SPDR S&P Biotech ETF by 8.3% during the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after purchasing an additional 882,718 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 2.9%

Shares of XBI opened at $147.01 on Friday. The stock has a market cap of $9.70 billion, a P/E ratio of 11.47 and a beta of 0.82. The business’s 50 day moving average price is $146.16 and its 200-day moving average price is $134.34. SPDR S&P Biotech ETF has a 52 week low of $84.39 and a 52 week high of $165.71.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.